Pathophysiology of drug-induced dyskinesias.
D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002090:Butyrophenones / Q000494:pharmacology; D002421:Caudate Nucleus / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D004671:Encephalitis, Arbovirus / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology; D009069:Movement Disorders / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy; D010640:Phenothiazines / Q000009:adverse effects* / Q000494:pharmacology; D011955:Receptors, Drug
D002090:Butyrophenones; D010640:Phenothiazines; D011955:Receptors, Drug; D004295:Dihydroxyphenylalanine; D004298:Dopamine